Our Recommendations
- Mejores prácticas para la atención de pacientes con tuberculosis (2017)
- WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update (2016)
- Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection (2016)
- Management of Tuberculosis: A Guide to the Essentials of Good Clinical Practice (2019)
- Field Guide for the Management of Drug-Resistant Tuberculosis (2018)
New Publications
- Community tuberculosis screening, testing and care, Uganda (2024)
- WHO operational handbook on tuberculosis: module 6: tuberculosis and comorbidities, 2nd ed (2024)
- Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance, 2nd ed (2023)
- Roadmap towards ending TB in children and adolescents, 3rd ed (2023)
- The use of next-generation sequencing for the surveillance of drug-resistant tuberculosis: an implementation manual (2023)
Filter
310
Featured
Recommendations
32
New Publications
30
Language
Document type
No document type
204
Guidelines
41
Manuals
23
Studies & Reports
15
Fact sheets
12
Training Material
8
Strategic & Response Plan
3
Online Courses
2
Situation Updates
1
Videos
1
Countries / Regions
Russia
7
Eastern Europe
5
Colombia
4
El Salvador
4
Western and Central Europe
4
Tajikistan
3
Ukraine
3
Argentina
3
India
3
Armenia
2
Global
2
Latin America and the Carribbean
2
Germany
2
Brazil
2
Ecuador
2
Kenya
1
Chile
1
Nigeria
1
Albania
1
Peru
1
Mozambique
1
USA
1
Africa
1
Asia
1
South–East Asia Region
1
South Africa
1
Uganda
1
Moldova
1
Authors & Publishers
Publication Years
Category
TB
69
Policies & Guidelines HIV & TB
21
Bacteriology
11
Pediatrics
8
Studies & Reports
3
Paediatrics
2
Diabetes
2
Medical Devices & Equipment
2
Disease Prevention & Control
2
Communicable Diseases
1
Hepatitis
1
Under-5 nutrition
1
Online Courses & Platforms
1
COVID-19
1
x MEDBOX Issue Brief & Annual Reports x
1
Monitoring & Evaluation
1
TB
1
Public Health
1
Training Manuals
1
Guidelines
1
Information, Education and Communication (IEC)
1
Capacity Building
1
Communicable Diseases
1
HIV & STI
1
Radiology and Diagnostic
1
Toolboxes
Detection & Diagnosis
102
Drug resistant TB
76
Adults
68
TB/HIV Coinfection
55
Children
47
Training
30
Prevention & Control
23
Clinical Guidelines
14
Childhood TB
9
Laboratory
7
Policies & Strategies
6
General
6
TB/HIV
6
HIV &TB
5
TB/COVID-19
4
El Salvador
4
Research & Access
4
TB
4
Eastern Europe & Central Asia
4
TB & Drug Abuse
3
Clinical Guidelines
3
Colombia
3
Brazil
3
Argentina
3
Ukraine
2
Children
2
Communication & Training
2
IEC Materials
2
TB
2
Prophylaxis
2
TB & Other Vulnerable Populations
2
Laboratory
2
Reports
2
Communication & Training
2
Advocacy & Communication
2
Essential Medicines
2
General
2
Policies and guidelines
2
TB & Prisoners
2
Disease Prevention & Control
2
Tuberculosis
2
Germany
2
HIV / AIDS
2
Outbreak Prevention & Control
1
Biosafety
1
Clinical Aspects, Treatment & Prevention
1
Treatment & Prevention
1
Vaccines & Immunization
1
Children & Adolescents
1
Pediatrics
1
Opportunistic Infections
1
Hepatitis
1
Treatment Guidelines HIV
1
People who injecting Drugs
1
IEC Materials
1
SOPs
1
Mozambique
1
Drug resistance
1
Clinical aspects
1
Russia
1
Clinical Guidelines
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Diagnostics & Laboratory Guidance
1
COVID-19
1
Latin America
1
Peru
1
Chile
1
Ecuador
1
Prices and Patents
1
Rational use of Medicine
1
Armenia
1
General Aspects
1
Prophylactic Treatment
1
Nigeria
1
Tajikistan
1
AmR (Region of Americas)
1
Antiretroviral Treatment ART
1
Kenya
1
Eastern and Southern Africa
1
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...
Las recomendaciones contenidas en este módulo son un componente de las directrices unificadas de la OMS sobre la tuberculosis (TB) y están destinadas principalmente para el uso de los programas nacionales de control de la tuberculosis, los organismos de salud pública y otros interesados clave que...
Guia rápido para profissionais de saúde
Orientações para gestores e profissionais de saúde
This rapid communication outlines the main outcomes of a WHO convened Guideline Development Group (GDG) meeting, held in May-June 2021 on the topic of the management of TB in children and adolescents. The rapid communication aims to inform staff from ministries of health and care providers across p...
The portable diagnostic imaging technology covered by this document will serve not only the pressing demands for tuberculosis screening and triage but also other diseases. Therefore, the requirements, accessories, hardware and software packages listed in the following specifications are described in...
Pan American Journal of Public Health.
Objetivo. Identificar os fatores associados ao êxito do tratamento da tuberculose multirresistente (TBMR) relacionados ao paciente e à equipe de saúde nos seis municípios da Colômbia com o maior número de casos. Métodos. Mediante regresiones logísticas...
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij...
Laboratory Safety Handbook. Global edition
Las pruebas de cultivo y sensibilidad a fármacos son necesarias especialmente para los pacientes con riesgo de tuberculosis resistente a los medicamentos y para vigilar su respuesta al tratamiento. Si bien el cultivo y las pruebas de sensibilidad son ca...
The results of the SHINE trial have been published in the NEJM today. SHINE looked at whether treatment for children with minimal TB could be reduced from 6 months to 4 months. It found that the four month treatment was as good as the standard six months treatment for children with minimal TB
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People with TB are usually more vulnerable to other infectio...
Tuberculosis (TB)
recommended
MEDBOX Issue Brief no. 19: World TB Day: Invest to end TB. Save Lives
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
WHO operational handbook on tuberculosis Module 5: Management of tuberculosis in children and adolescents
recommended
The practical guidance in the operational handbook aims to inform the development or revision of national policies and related implementation guidance on the management of TB in children and adolescents under programmatic circumstances and at different levels of the health system. The operational ha...
El agente etiológico de la tuberculosis es el Mycobacterium tuberculosis o bacilo de Koch. Se trata de un bacilo aerobio estricto, ácido-alcohol resistente, sin movilidad, de crecimiento lento y que se inactiva con rayos ultravioleta y temperaturas mayores de 60°C.
